Dupilumab unmasking cutaneous T-cell lymphoma: report of a fatal case
Clin Exp Dermatol
.
2022 May;47(5):974-976.
doi: 10.1111/ced.15079.
Epub 2022 Feb 9.
Authors
Elizabeth F M Poyner
1
2
,
Chris M Bacon
3
4
,
Wendy Osborne
5
,
John A Frew
6
,
Sophie C Weatherhead
2
Affiliations
1
Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
2
Department of Dermatology, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
3
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
4
Department of Cellular Pathology, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
5
Department of Haematology, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
6
Department of Oncology, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
PMID:
34939237
DOI:
10.1111/ced.15079
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Monoclonal, Humanized / adverse effects
Humans
Lymphoma, T-Cell, Cutaneous* / drug therapy
Skin Neoplasms* / drug therapy
Substances
Antibodies, Monoclonal, Humanized
dupilumab